N-methyl-4-nitroaniline

oxan-4-one

(E)-ethyl but-2-enoate

3-methylbut-2-enoic acid

6-nitro-2,3-dihydro-1H-inden-1-one

(4aS,4bS,6aS,7S,9aS,9bS,11aR)-N-((1H-imidazo[4,5-b]pyridin-2-yl)methyl)-3-fluoro-1,4a,6a-trimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide

(S)-methyl 2-amino-3-(3,4-dihydroxyphenyl)propanoate hydrochloride

2-(2,6-dioxopiperidin-3-yl)-4-nitroisoindoline-1,3-dione

(2'R,8R,9S,10R,13S,14S)-10,13-dimethyl-1,8,9,10,11,12,13,14,15,16-decahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-3,5'(2H,4'H)-dione;canrenone

2-(4-oxocyclohexyl)isoindoline-1,3-dione

(1R,3aR,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysen-9-ol

(S)-4-methyl-N-((S)-1-(((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide

1-(piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one hydrochloride

(8R,9S,10R,13S,14S)-17-acetyl-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15-decahydro-1H-cyclopenta[a]phenanthren-3(2H)-one

1-benzhydryl-4-(3-phenylallyl)piperazine

2-nitrosooctahydrocyclopenta[c]pyrrole

8-chloro-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione compound with 2-(benzhydryloxy)-N,N-dimethylethanamine (1:1)

2-amino-9-((2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxytetrahydrofuran-2-yl)-3H-purin-6(9H)-one

Brivaracetam impurity 232

2-amino-N-((R)-1-(((R)-1-formamido-2-(1H-indol-3-yl)ethyl)amino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl)-2-methylpropanamide acetate